Chemically Induced Birth Defects
Chemically Induced Birth Defects
复制标题
DOI:
10.1038/sj.jp.7210778
复制
发表时间:
2002-12
影响因子:
2.9
通讯作者:
R. Kirby
中科院分区:
文献类型:
--
作者:
R. Kirby
Seeing a new edition of this classic and informative text is like visiting an old college classmate after an absence of many years—the contours of shared experience form the basis for renewal through updating the path of life’s course in the intervening period. Schardein has retained the basic structure of his compendious reference work while incorporating new information and revising sections where studies from animal models, toxicology, and developmental and reproductive epidemiology have provided new insights. The purpose of the text, in the author’s words, is ‘‘to catalog the available data on drugs and chemicals with respect to their potential teratogenicity in animals and humans’’(p. vi). This is accomplished through a series of chapters, divided into two parts, one focused on drugs, and the other on chemicals, which follow an introduction to the principles of teratogenesis relevant to drug and chemical exposures. Most of the substantive chapters are organized in a familiar manner, beginning with a general introduction, then taking each class of potential exposures in turn, first reviewing the literature on animal studies and then considering the research in humans. The chapters end with a concluding section and a lengthy set of references. Approximately three-fourths of the text is devoted to drugs and their effects on the developing fetus. This section includes 23 separate chapters, covering medications used to treat specific diseases and organisms as well as drugs used for body system-specific ailments. There are also chapters on food additives and dietary issues, and on ‘‘personal and social drugs.’’The chapters vary in comprehensiveness and balance between animal model and human studies. The text is not current in some areas. For example, birth defects surveillance in the United States has progressed rapidly in the 1990s beyond the point discussed on p. 80, and the reference to the number of pregnancies affected by anticonvulsant therapy each year dates to 1984 (p. 179). On the other hand, the chapter on thalidomide reflects recent developments in its use and national postmarketing surveillance activities.